Notice of Winter Holidays
Mediplus Pharmaceuticals Co., Ltd. will be closed for winter holidays from Thursday, December 28, 2024, to Sunday, January 5, 2025.
During this period, we will continue to receive inquiries via fax and email; however, please note that we will not be responding to inquiries or processing orders until we resume operations.
We apologize for any inconvenience this may cause and appreciate your understanding.
Our Director’s Interview Featured in WWD BEAUTY JAPAN
In the August 26, 2024 issue of WWD BEAUTY(published by WWD JAPAN) an interview with our Director and Executive Fellow, Gotaro Shioda, was featured under the title “The Potential of ‘Ozonized Glycerin’ for Dramatic Skin Regeneration Without Side Effects” in the article “BEAUTY RESEARCHERS Vol.8”.
Read moreExhibited at the Institute for Predictable Osseointegration in Implantology (IPOI)
On Sunday, July 7, 2024, we exhibited at the Institute for Predictable Osseointegration in Implantology (IPOI), a non-profit organization (NPO) event held in Fukuoka City.
Read more
Presentation on the efficacy of Ozonized Glycerin (Novel Glycerin Compound) formulation for Atopic Dermatitis at the Japanese Dermatological Association
Mediplus Pharma, Inc. presented the safety and efficacy of its proprietary ingredient, ozonized glycerin (Novel Glycerin Compound), in formulations for atopic dermatitis at the 123rd Annual Meeting of the Japanese Dermatological Association. The conference was held from June 6 to June 9, 2024, at the Kyoto International Conference Center.
For more details on the press release, please visit here.
https://prtimes.jp/main/html/rd/p/000000015.000079724.html
Presentation on Multifunctionality of Ozonized Glycerin （Novel Glycerin Compounds) and Their Application as Biomaterials at the World Biomaterials Congress
Mediplus Pharma, Inc. (CEO: Kenji Ito, HQ: Shibuya, Tokyo) presented on the multifunctionality and application of its proprietary ingredient, ozonized glycerin (Novel Glycerin Compound), as biomaterials at the 12th World Biomaterials Congress (WBC), held over six days from May 26 to 31, 2024, in Daegu, South Korea.
For more details on the press release, please visit here.
https://prtimes.jp/main/html/rd/p/000000013.000079724.html
Announcement of Exhibition at the Institute for Predictable Osseointegration in Implantology Academic Conference
We are pleased to announce our participation in the 16th Academic Conference of the Non-Profit Organization (NPO) Institute for Predictable Osseointegration in Implantology, which will be held on Sunday, July 7, 2024, in Fukuoka City.
We aim to introduce our unique ingredient , ozonized glycerin, which is expected to have beneficial effects in dental medicine, particularly in the surgical field. This event will be an opportunity for dental professionals, especially those active in the surgical domain, to learn about our product.
At our exhibition booth, attendees will be able to experience ozonized glycerin and deepen their understanding through explanations from the developers.
Presentation on the Efficacy of Novel Glycerin Compounds for Atopic Dermatitis at AAD
A presentation on the safety and efficacy evaluation of atopic dermatitis was held at the American Academy of Dermatology (AAD) in March, and it has been featured in the “Health Industry Distribution Newspaper” issue 1111 (published on 4/25).
We plan to continue utilizing Novel Glycerin Compounds (ozonized glycerin) extensively in the business ventures undertaken by our group companies in the future.
For the AAD presentation release, please visit:
Announcement of New Patent Information Page Launch
We are pleased to announce the launch of our new patent information page.
PATENT
This page provides disclosures of the patent registration information that we possess. Interested parties are invited to explore this resource to better understand it further.
Mediplus Pharma, Inc. has received RSPO supply chain certification
We are pleased to announce that Mediplus Pharma, Inc. has received RSPO supply chain certification (Model: Mass Balance, MB).
RSPO, officially known as the Roundtable on Sustainable Palm Oil, is a non-profit organization comprised of seven stakeholders involved in palm oil.
The Supply Chain Certification System (SC certification) is a system that certifies that the requirements are met at each stage of the manufacturing, processing, and distribution process for products made with Certified Palm Oil. Organizations that have ownership of SC certified products in each process until the final product is made are eligible for certification.
Cultivating sustainability for people and planet – Roundtable on Sustainable Palm Oil (RSPO)
By acquiring the Supply Chain Certification, a universal certification standard, we are able to participate more closely in the sustainable production of palm oil.
Hopefully, we should consider SDGs fully and will ensure transparency in business and consequently environmental protection of the entire planet. As a company with such intention, we will make effective use of this certification and continue to make untiring efforts to achieve our MISSION and VISION, “Contribute to a society where humans, animals, and plants can lead healthy lives”.